عربى
English
Be A Partner
Social Responsibility
Students Training
IR
Investor Relations
Financial Charts
Annual Reports
News
PRESS RELEASES
SOCIAL EVENTS
CONFERENCES
Careers
Covid-19
Report a side effect
Contact Us
Branches
Home
We are Eipico
We are Eipico
EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
Uniqueness
WHO Approval
Sterile products Area
Automatic Ampoules Inspection
Eipico Ophthalmology
Primary packaging materials
Restricted-access barrier system
Distribution Channel
Our History
Vision, Mission & Values
Chairman Message
Eipico Employees
Manufacturing Facilities
Media Library
Global
Global
EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
Eipico Destination
Manufacturing Facilities
Manufacturing Facilities
EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
Factory 1
Factory 2
Factory 3 (Biotechnology)
Eiaco Factory
Batterjee Factory
EIPICO Plastic Factory
R&D And Quality
R&D And Quality
EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
Quality Assurance
Quality Control
R&D
Regulatory Affairs
Global Accreditation
Track and Trace
Products
Products
EIPICO produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
Eipico Products
By Alphabet
Biotechnology
We're sorry, but our website doesn't work properly without JavaScript enabled.
Press Releases
You are here :
>>News
>>Press Releases
ايبيكو تنتج عقار كوفابرافير "مولنوبيرافير" احدث دواء للعلاج من الكورونا
د. أحمد كيلانى: 80 مليون دولار استثمارات شركة أفرى أبى لتصنيع الخامات الدوائية برأسمال مليار جنيه
Dr. Ahmed Kelani: EIPICO exports $4.7 Million to Tanzania before the end of February 2022
حوار هام جدا لجريدة أخبار اليوم - دكتور/ أحمد كيلانى رئيس مجلس الإدارة والعضو المنتدب لشركة ايبيكو للأدوية وبداية و لا اروع لعام 2022
EIPICO’s QC Labs were EGAC accredited
EIPICO : Outstanding Achievements In The first 9 Months Of 2021 Total sales 2.4 EGP Billion
بتكلفة تزيد عن 43,5 مليون دولار تمت الموافقة على اسناد انشاء مصنع ايبيكو 3
وزير الصحة بالسودان يزور شركة أيبيكو للادوية أكبر شركات أكديما
تسجيل 7 مستحضرات حيوية وبيولوجية لعلاج الأورام والروماتويد - و تصدير مستحضر ريمايست " ريمديسفير " للعراق و اقليم كردستان ، وجارى التصدير لاوغندا
شراكة بين السودان ومصر في مجال إنتاج وتصنيع الادوية بالخرطوم
EIPICO’s General Assembly renews confidence in Dr. Ahmed Kelani as a Chairman of the Board of Directors and The Managing Director
Dr. Ahmed Kelani Signs Memorandum of Understanding for joint pharmaceutical manufacturing in the Egyptian-Kazakh Business Forum.
Dr. Kelani discusses with the Ambassador of Belarus ways to support industrial cooperation and exchange experiences in all fields.
Egypt Labor Union honors Dr. Ahmed Kelani.
Dr. Ahmed Kelani – EIPICO Chairman - announced to Masrawy – Press News -That "Epifluver" the treatment for Corona patients - known internationally as Avigan – produced by EIPICO will be in Market soon.
Mr. Mohamed Saafan - Manpower Minister receives Dr. Ahmed Kelani to discuss the ways of mutual Cooperation, Social and Healthcare for EIPICO employees.
EIPICO to begin producing of “ Epifluovir “ – favipiravir- for covid-19 patients and manufacturing ” Remicovir “ - remdesivir soon.
EIPICO- Pharmaceutical Company - is standing beside home Country to confront the Corona epidemic.
General Assembly meeting of EIPICO company.
Dr. Ahmed Kelani: Political Support staying behind increasing Egyptian-Belarusian trade exchange.
Cooperation between " Federation of chambers of Commerce, and "Egyptian-Belarus Business Council" in order to expand trade exchange and establish joint investments.
EIPICO acquires 9.77% of the shares of the Medical Union Pharmaceuticals Company
EIPICO will begin construction of its new plant early next year with an investment of Billion L.E.
EIPICO is a friendly Environment company. Environment Minister visits EIPICO pharmaceutical factory and praises the advanced performance of the pharmaceuticals production stages.
During the first five months of this year, EIPICO pharmaceuticals company achieved sales growth of 19.9%, which representing 3.8% of the Egyptian pharmaceutical market.
Сompany results of the first quarter of the current year
EIPICO acquires 29% of Egyptian medicine exports and seeks to get in 15 countries within 3 years
...
Previous
1
Next
...
Pages count = 1
All items count = 27